PT  - JOURNAL ARTICLE
AU  - Vahidy, Farhaan S.
AU  - Nicolas, Juan Carlos
AU  - Meeks, Jennifer R.
AU  - Khan, Osman
AU  - Jones, Stephen L.
AU  - Masud, Faisal N.
AU  - Sostman, H. Dirk
AU  - Phillips, Robert A.
AU  - Andrieni, Julia D.
AU  - Kash, Bita
AU  - Nasir, Khurram
TI  - Racial and Ethnic Disparities in SARS-CoV-2 Pandemic: Analysis of a COVID-19 Observational Registry for a Diverse U.S. Metropolitan Population
AID  - 10.1101/2020.04.24.20073148
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.24.20073148
4099  - http://medrxiv.org/content/early/2020/05/12/2020.04.24.20073148.short
4100  - http://medrxiv.org/content/early/2020/05/12/2020.04.24.20073148.full
AB  - Introduction Data on race and ethnic susceptibility to SARS-CoV-2 infection are limited. We analyzed socio-demographic factors associated with higher likelihood of SARS-CoV-2 infection and explore mediating pathways for race disparities in the SARS-CoV-2 pandemic.Methods Cross sectional analysis of COVID-19 Surveillance and Outcomes Registry (CURATOR), which captures data for a large healthcare system comprising of one central tertiary care, seven large community hospitals, and an expansive ambulatory / emergency care network in the Greater Houston area. Nasopharyngeal samples for individuals inclusive of all ages, races, ethnicities and sex were tested for SARS-CoV-2. We analyzed, socio-demographic (age, sex, race, ethnicity, household income, residence population density) and comorbidity (hypertension, diabetes, obesity, cardiac disease) factors. Multivariable logistic regression models were fitted to provide adjusted Odds Ratios (aOR), 95% confidence intervals (CI) for likelihood of positive SARS-CoV-2 test. Structural Equation Modeling (SEM) framework was utilized to explore three mediation pathways (low income, high population density, high comorbidity burden) for association between African American race and SARS-CoV-2 infection.Results Among 4,513 tested individuals, 754 (16.7%) tested positive. Overall mean (SD) age was 50.6 (18.9) years, 62% females and 26% were African American. African American race was associated with lower socio-economic status, higher comorbidity burden, and population density residence. In the fully adjusted model, African American race (vs. White; aOR, CI: 1.84, 1.49-2.27) and Hispanic ethnicity (vs. non-Hispanic; aOR, CI: 1.70, 1.35-2.14) had a higher likelihood of infection. Older individuals and males were also at a higher risk of SARS-CoV-2 infection. The SEM framework demonstrated a statistically significant (p = 0.008) indirect effect of African American race on SARS-CoV-2 infection mediated via a pathway that included residence in densely populated zip code.Conclusions There is strong evidence of race and ethnic disparities in the SARS-CoV-2 pandemic potentially mediated through unique social determinants of health.Strengths and limitations of this studyOne of the first studies to systematically evaluate race and ethnic disparities in susceptibility to SARS-CoV-2 infection, while accounting for multiple sociodemographic characteristics and comorbiditiesStudy population represents a large and diverse metropolitan of the U.S. with data from one of the largest healthcare providers across the greater metropolitan areaStudy evaluates potential mediation pathways for race disparities and demonstrates that residence in areas with high population density may mediate race disparities in susceptibility to SARS-CoV-2 infectionSingle center study with limited information about true burden of comorbidity and lifestyle factorsCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis work was internally funded by the Houston Methodist Academic Institute.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData requests can be made to the corresponding author and will be evaluated by the appropriate institutional committees on a case by case basis.